Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug
NeutralFinancial Markets

Ananda Pharma has concluded its trials for an epilepsy drug and is now redirecting its efforts towards developing a treatment for endometriosis. This shift is significant as it highlights the company's adaptability in addressing pressing health issues, particularly in women's health, which often lacks sufficient research and treatment options.
— Curated by the World Pulse Now AI Editorial System